<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fang X</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>National Institute of Child Health and Human Development</funding><pagination>160-173</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11911005</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>194(2)</volume><pubmed_abstract>Rett syndrome (RTT) is a progressive neurodevelopmental disorder, and pathogenic Methyl-CpG-binding Protein 2 (MECP2) variants are identified in >95% of individuals with typical RTT. Most of RTT-causing variants in MECP2 are de novo and usually on the paternally inherited X chromosome. While paternal age has been reported to be associated with increased risk of genetic disorders, it is unknown whether parental age contributes to the risk of the development of RTT. Clinical data including parental age, RTT diagnostic status, and clinical severity are collected from 1226 participants with RTT and confirmed MECP2 variants. Statistical analyses are performed using Student t-test, single factor analysis of variance (ANOVA), and multi-factor regression. No significant difference is observed in p</pubmed_abstract><journal>American journal of medical genetics. Part A</journal><pubmed_title>Parental age effects and Rett syndrome.</pubmed_title><pmcid>PMC11911005</pmcid><funding_grant_id>P50 HD103537</funding_grant_id><funding_grant_id>U54 HD061222</funding_grant_id><pubmed_authors>Benke TA</pubmed_authors><pubmed_authors>Annese FE</pubmed_authors><pubmed_authors>Marsh ED</pubmed_authors><pubmed_authors>Lane JB</pubmed_authors><pubmed_authors>Fang X</pubmed_authors><pubmed_authors>Percy AK</pubmed_authors><pubmed_authors>Baggett LM</pubmed_authors><pubmed_authors>Motil KJ</pubmed_authors><pubmed_authors>Caylor RC</pubmed_authors><pubmed_authors>Neul JL</pubmed_authors><pubmed_authors>Skinner SA</pubmed_authors><pubmed_authors>Glaze DG</pubmed_authors><pubmed_authors>Barrish JO</pubmed_authors></additional><is_claimable>false</is_claimable><name>Parental age effects and Rett syndrome.</name><description>Rett syndrome (RTT) is a progressive neurodevelopmental disorder, and pathogenic Methyl-CpG-binding Protein 2 (MECP2) variants are identified in >95% of individuals with typical RTT. Most of RTT-causing variants in MECP2 are de novo and usually on the paternally inherited X chromosome. While paternal age has been reported to be associated with increased risk of genetic disorders, it is unknown whether parental age contributes to the risk of the development of RTT. Clinical data including parental age, RTT diagnostic status, and clinical severity are collected from 1226 participants with RTT and confirmed MECP2 variants. Statistical analyses are performed using Student t-test, single factor analysis of variance (ANOVA), and multi-factor regression. No significant difference is observed in p</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-02T07:18:40.571Z</modification><creation>2025-04-05T12:38:52.561Z</creation></dates><accession>S-EPMC11911005</accession><cross_references><pubmed>37768187</pubmed><doi>10.1002/ajmg.a.63396</doi></cross_references></HashMap>